Mira Pharmaceuticals initiated with Buy rating and $3.50 target
Maxim Group initiated coverage on MIRA Pharmaceuticals with a Buy rating and a $3.50 per-share price target,
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.